Asthma Trial, Recruiting NCT07261423 Sponsor: University of Pittsburgh Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07261423
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 8 to 17 years old
  • People who have been diagnosed by a healthcare provider with persistent asthma (moderate to severe levels) or mild intermittent asthma that has led to at least one serious asthma attack in the past 12 months — where a serious attack means needing steroid medication for at least 3 days, or a visit to an Emergency Department or Urgent Care that required steroid treatment
  • People who have had an asthma check-up with a healthcare provider in the past year
  • People whose main home is in Allegheny County, PA
  • People who have access to a smartphone or the internet at home
  • Only one person per household may participate

Who may not be able to join:

  • People who have another active long-term breathing condition, such as cystic fibrosis (confirm with trial site for other conditions that may apply)
  • People who have a neuromuscular disorder (a condition affecting the nerves and muscles)
  • People who have a long-term condition that limits their ability to walk or move around independently, such as spastic quadriplegia (confirm with trial site for other conditions that may apply)
  • People who have a heart condition involving low oxygen levels in the blood (cyanotic heart disease)
  • People who are planning to move out of Allegheny County, PA within the next 12 months
  • People who have used certain steroid medicines — including nasal sprays or oral, injected, or intravenous steroids — within the 4 weeks before the trial's assignment process begins
  • People who are currently taking part in another clinical trial focused on asthma treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Franziska Rosser, MD MPH, University of Pittsburgh

Phone: 877-296-9026

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
24 February 2026
Est. completion
1 January 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in asthma control scores, over-time, between groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov